The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
Steven M. Haffner
Department of Medicine, University of Texas Health Science Center
at San Antonio, San Antonio, Texas 78284-7873
I. Introduction
II. Correlation Between Hyperglycemia andCVD
A. Type 2 diabetes
B. Elevated glucose concentrationsin the nondiabetic range
C. Atherosclerosis in subjects withasymptomatic hyperglycemia
III. Causal Relationship of PostprandialHyperglycemia to CVD
A. Direct effects of hyperglycemia
B.Insufficient insulin production
C. Insulin resistance andhyperinsulinemia
D. Association with risk factors for CVD
IV. Therapeutic Interventions for Type 2 Diabetes
A. Insulintherapy
B. Sulfonylureas
C. Biguanides
D. Acarbose
V.Studies to Prevent Type 2 Diabetes
VI. Conclusions
This article has been cited by other articles:
H. Wang, R. Li, and Y. Hu The Alternative Noncoding Exons 1 of Aromatase (Cyp19) Gene Modulate Gene Expression in a Posttranscriptional Manner
Endocrinology,
July 1, 2009;
150(7):
3301 - 3307.
[Abstract][Full Text][PDF]
A. Stancakova, M. Javorsky, T. Kuulasmaa, S. M. Haffner, J. Kuusisto, and M. Laakso Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men
Diabetes,
May 1, 2009;
58(5):
1212 - 1221.
[Abstract][Full Text][PDF]
B. Fagerberg, H. Schuster, G. S. Birketvedt, S. Tonstad, K. P. Ohman, and I. Gause-Nilsson Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPAR{alpha}/{gamma} agonist, tesaglitazar
Diabetes and Vascular Disease Research,
September 1, 2007;
4(3):
174 - 180.
[Abstract][PDF]
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin
Endocr. Rev.,
August 1, 2007;
28(5):
463 - 491.
[Abstract][Full Text][PDF]
P. H. McNulty, M. A. Tulli, B. J. Robertson, V. Lendel, L. A. Harach, S. Scott, and J. P. Boehmer Effect of simulated postprandial hyperglycemia on coronary blood flow in cardiac transplant recipients
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H103 - H108.
[Abstract][Full Text][PDF]
M. E. Tushuizen, R. Nieuwland, C. Rustemeijer, B. E. Hensgens, A. Sturk, R. J. Heine, and M. Diamant Elevated Endothelial Microparticles Following Consecutive Meals Are Associated With Vascular Endothelial Dysfunction in Type 2 Diabetes
Diabetes Care,
March 1, 2007;
30(3):
728 - 730.
[Full Text][PDF]
S. Ghosh, Y. Lu, A. Katz, Y. Hu, and R. Li Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E246 - E252.
[Abstract][Full Text][PDF]
I. W Campbell The role of metformin and pioglitazone in early combination treatment of type 2 diabetes mellitus
The British Journal of Diabetes & Vascular Disease,
September 1, 2006;
6(5):
207 - 215.
[Abstract][PDF]
F. Cavalot, A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, M. Conti, G. Anfossi, G. Costa, and M. Trovati Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study
J. Clin. Endocrinol. Metab.,
March 1, 2006;
91(3):
813 - 819.
[Abstract][Full Text][PDF]
Y. Kataoka, S. Yasuda, I. Morii, Y. Otsuka, A. Kawamura, and S. Miyazaki Quantitative Coronary Angiographic Studies of Patients With Angina Pectoris and Impaired Glucose Tolerance
Diabetes Care,
September 1, 2005;
28(9):
2217 - 2222.
[Abstract][Full Text][PDF]
H. Taegtmeyer Glucose for the Heart: Too Much of a Good Thing?
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
49 - 50.
[Full Text][PDF]
A. Gallo, G. Ceolotto, P. Pinton, E. Iori, E. Murphy, G. A. Rutter, R. Rizzuto, A. Semplicini, and A. Avogaro Metformin Prevents Glucose-Induced Protein Kinase C-{beta}2 Activation in Human Umbilical Vein Endothelial Cells Through an Antioxidant Mechanism
Diabetes,
April 1, 2005;
54(4):
1123 - 1131.
[Abstract][Full Text][PDF]
M E Tushuizen, M Diamant, and R J Heine Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes
Postgrad. Med. J.,
January 1, 2005;
81(951):
1 - 6.
[Abstract][Full Text][PDF]
C. Meyer, H. J. Woerle, J. M. Dostou, S. L. Welle, and J. E. Gerich Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes
Am J Physiol Endocrinol Metab,
December 1, 2004;
287(6):
E1049 - E1056.
[Abstract][Full Text][PDF]
A. Festa, R. D'Agostino Jr., A. J.G. Hanley, A. J. Karter, M. F. Saad, and S. M. Haffner Differences in Insulin Resistance in Nondiabetic Subjects With Isolated Impaired Glucose Tolerance or Isolated Impaired Fasting Glucose
Diabetes,
June 1, 2004;
53(6):
1549 - 1555.
[Abstract][Full Text][PDF]
A. S. Reed, N. Charkoudian, A. Vella, P. Shah, R. A. Rizza, and M. J. Joyner Forearm vascular control during acute hyperglycemia in healthy humans
Am J Physiol Endocrinol Metab,
March 1, 2004;
286(3):
E472 - E480.
[Abstract][Full Text]
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Endocr. Rev.,
February 1, 2004;
25(1):
153 - 175.
[Abstract][Full Text][PDF]
D. K. Plante and J. L. Nadler Diabetes and Vascular Disease
Seminars in Cardiothoracic and Vascular Anesthesia,
September 1, 2003;
7(3):
295 - 310.
[Abstract][PDF]
J. E. Gerich Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
Arch Intern Med,
June 9, 2003;
163(11):
1306 - 1316.
[Abstract][Full Text][PDF]
J. E. Gerich Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus
Mayo Clin. Proc.,
April 1, 2003;
78(4):
447 - 456.
[Abstract][PDF]
H. J. Woerle, C. Meyer, J. M. Dostou, N. R. Gosmanov, N. Islam, E. Popa, S. D. Wittlin, S. L. Welle, and J. E. Gerich Pathways for glucose disposal after meal ingestion in humans
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E716 - E725.
[Abstract][Full Text][PDF]
A. J Krentz, R. Mani, and C. P Shearman Review: Peripheral arterial disease in diabetes: time for a co-ordinated approach to management
The British Journal of Diabetes & Vascular Disease,
March 1, 2003;
3(2):
92 - 96.
[Abstract][PDF]
N. N. Wahab, E. A. Cowden, N. J. Pearce, M. J. Gardner, H. Merry, J. L. Cox, and ICONS Investigators Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
J. Am. Coll. Cardiol.,
November 20, 2002;
40(10):
1748 - 1754.
[Abstract][Full Text][PDF]
N. Charkoudian, A. Vella, A. S. Reed, C. T. Minson, P. Shah, R. A. Rizza, and M. J. Joyner Cutaneous vascular function during acute hyperglycemia in healthy young adults
J Appl Physiol,
October 1, 2002;
93(4):
1243 - 1250.
[Abstract][Full Text][PDF]
M.J. Sampson, I.R. Davies, J.C. Brown, K. Ivory, and D.A. Hughes Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients
Arterioscler Thromb Vasc Biol,
July 1, 2002;
22(7):
1187 - 1193.
[Abstract][Full Text][PDF]
C. Parkinson, W. M. Drake, M. E. Roberts, K. Meeran, G. M. Besser, and P. J. Trainer A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1797 - 1804.
[Abstract][Full Text][PDF]
P. A. Watson, A. Nesterova, C. F. Burant, D. J. Klemm, and J. E.-B. Reusch Diabetes-related Changes in cAMP Response Element-binding Protein Content Enhance Smooth Muscle Cell Proliferation and Migration
J. Biol. Chem.,
November 30, 2001;
276(49):
46142 - 46150.
[Abstract][Full Text][PDF]
G. Ceolotto, A. Gallo, M. Sartori, R. Valente, E. Baritono, A. Semplicini, and A. Avogaro Hyperglycemia Acutely Increases Monocyte Extracellular Signal-Regulated Kinase Activity in Vivo in Humans
J. Clin. Endocrinol. Metab.,
March 1, 2001;
86(3):
1301 - 1305.
[Abstract][Full Text]
S. Uemura, H. Matsushita, W. Li, A. J. Glassford, T. Asagami, K.-H. Lee, D. G. Harrison, and P. S. Tsao Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase Activity : Role of Oxidative Stress
Circ. Res.,
June 22, 2001;
88(12):
1291 - 1298.
[Abstract][Full Text][PDF]